# Impact Validation

## Impacts

* **Improved Participation** - from patients **and** researchers which is an outcome the industry will support and an everybody-wins scenario
* **Reduced Regulatory Burden** - 10 years is the average for a drug hit the market for drug approval TK

## How Impact to be Measured

1. Reduced regulatory burden on investigators and research site staff.
    1. As measured by regulatory infractions and user experience surveys with comparisons.
1. Increased patient engagement and satisfaction.
    1. As measured by a survey and compliance
1. Implementation working group discussions with stakeholder steering committees reprenting CROs, Patient Groups, PIs, and Pharma/Biotech companies.
